- 01Metabolic research · 2 min read
GLP-1, GIP and glucagon: how metabolic peptide signals work
GLP-1, GIP and glucagon are peptide hormones that help coordinate metabolism. They are related signals, but they act through different receptors and do not do the same job.
- 02Metabolic research · 2 min read
Comparing amylin and GLP 1 research without inventing a winner
Eloralintide and semaglutide belong in a comparison of biological strategies, but they should not be treated as interchangeable products. Eloralintide was developed as a selective…
- 03Metabolic research · 2 min read
What an active comparator adds to eloralintide research
An active comparator makes a trial more useful by asking how a new approach performs against an existing medicine rather than only against placebo. The EloraTZP phase 2b program included…
- 04Metabolic research · 2 min read
Eloralintide and retatrutide represent different research strategies
Eloralintide and retatrutide are often grouped together as emerging obesity medicines, but their research questions differ. Eloralintide is an amylin-receptor agonist. Retatrutide combines…
- 05Metabolic research · 2 min read
CagriSema and Retatrutide Require Different Evidence Questions
CagriSema and retatrutide illustrate two approaches to investigating obesity treatment. CagriSema combines cagrilintide with semaglutide. Retatrutide is a single investigational molecule…
- 06Research literacy · 2 min read
Randomized and Placebo-Controlled Trials: What Are Researchers Measuring?
Understand randomization, placebo controls, blinding, and clinical endpoints, including why a biomarker change may not establish patient benefit.
Reading journey
Two impressive results. A fair comparison?
Connect receptor biology, emerging metabolic treatments and the study-design choices that prevent false rankings.
